Simplex Trading
ELV icon

Simplex Trading’s Elevance Health ELV Stock Holding History

Simplex Trading’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.33M Buy
+18,200
New +$5.98M ﹤0.01% 1072
2025
Q4 		– Sell
-66,200
Closed -$21.4M – 8914
2025
Q3 		$21.4M Buy
66,200
+37,200
+128% +$11.6M 0.01% 612
2025
Q2 		$11.3M Sell
29,000
-39,100
-57% -$15.7M 0.01% 814
2025
Q1 		$29.6M Sell
68,100
-16,500
-20% -$6.62M 0.02% 404
2024
Q4 		$31.2M Buy
84,600
+57,700
+214% +$24.1M 0.02% 451
2024
Q3 		$14M Sell
26,900
-7,500
-22% -$4.01M 0.01% 827
2024
Q2 		$18.6M Sell
34,400
-20,200
-37% -$10.7M 0.01% 650
2024
Q1 		$28.3M Buy
54,600
+1,100
+2% +$547K 0.02% 529
2023
Q4 		$25.2M Buy
53,500
+26,000
+95% +$12M 0.02% 618
2023
Q3 		$12M Buy
27,500
+5,700
+26% +$2.59M 0.01% 843
2023
Q2 		$9.69M Buy
21,800
+5,600
+35% +$2.58M 0.01% 908
2023
Q1 		$7.45M Buy
16,200
+3,300
+26% +$1.57M 0.01% 1057
2022
Q4 		$6.62M Sell
12,900
-29,200
-69% -$14.8M 0.01% 1068
2022
Q3 		$19.1M Buy
42,100
+27,900
+196% +$13.3M 0.02% 527
2022
Q2 		$6.85M Sell
14,200
-12,900
-48% -$6.38M 0.01% 968
2022
Q1 		$13.3M Sell
27,100
-6,000
-18% -$2.74M 0.01% 702
2021
Q4 		$15.3M Sell
33,100
-35,500
-52% -$14.9M 0.02% 604
2021
Q3 		$26.3M Sell
68,600
-200
-0.3% -$76K 0.02% 383
2021
Q2 		$26.3M Buy
68,800
+68,009
+8,598% +$26M 0.03% 369
2021
Q1 		$28.4M Buy
791
+212
+37% +$68.2K 0.05% 222
2020
Q4 		$18.6M Buy
579
+195
+51% +$59.8K 0.02% 376
2020
Q3 		$10.3M Buy
384
+50
+15% +$13.5K 0.01% 505
2020
Q2 		$8.78M Sell
334
-472
-59% -$126K 0.01% 568
2020
Q1 		$18.3M Sell
806
-345
-30% -$94K 0.03% 258
2019
Q4 		$34.8M Buy
1,151
+405
+54% +$111K 0.08% 165
2019
Q3 		$17.9M Sell
746
-561
-43% -$154K 0.05% 259
2019
Q2 		$36.9M Buy
1,307
+985
+306% +$269K 0.1% 127
2019
Q1 		$9.24M Buy
322
+156
+94% +$45.1K 0.03% 418
2018
Q4 		$4.36M Sell
166
-53
-24% -$14.6K 0.01% 636
2018
Q3 		$6M Buy
219
+68
+45% +$17.7K 0.02% 539
2018
Q2 		$3.59M Buy
151
+44
+41% +$10.2K 0.01% 737
2018
Q1 		$139K Sell
107
-315
-75% -$74K 0.01% 1527
2017
Q4 		$66K Buy
422
+38
+10% +$8.09K ﹤0.01% 2168
2017
Q3 		$68K Sell
384
-335
-47% -$63.8K ﹤0.01% 2018
2017
Q2 		$147K Sell
719
-238
-25% -$42.8K 0.01% 1436
2017
Q1 		$161K Sell
957
-209
-18% -$33.2K 0.01% 1378
2016
Q4 		$101K Buy
1,166
+154
+15% +$20.6K 0.01% 1519
2016
Q3 		$150K Buy
1,012
+509
+101% +$65.7K 0.01% 1240
2016
Q2 		$112K Sell
503
-102
-17% -$14K 0.01% 1397
2016
Q1 		$120K Buy
605
+509
+530% +$68K 0.01% 1208
2015
Q4 		$29K Sell
96
-205
-68% -$28.2K ﹤0.01% 2373
2015
Q3 		$158K Buy
301
+9
+3% +$1.35K 0.01% 1072
2015
Q2 		$47K Buy
292
+218
+295% +$34.8K ﹤0.01% 1740
2015
Q1 		$2K Buy
+74
New +$10.5K ﹤0.01% 4084

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Simplex Trading's ELV Position: Q4 2025 in Review

Simplex Trading sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 27,588 shares — an estimated $8.91M sold.

Simplex Trading first reported a position in ELV in Q4 2014 and held it in 25 quarters. The position peaked at $12.3M in Q2 2019. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Simplex Trading reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 27,588 Elevance Health shares in Q4 2025, an estimated $8.91M.
  • Simplex Trading first reported a position in Elevance Health in Q4 2014 and held it in 25 quarters.
  • Simplex Trading's Elevance Health position peaked at $12.3M in Q2 2019.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.